Canada markets open in 55 minutes
  • S&P/TSX

    20,164.39
    -36.26 (-0.18%)
     
  • S&P 500

    4,241.84
    -4.60 (-0.11%)
     
  • DOW

    33,874.24
    -71.34 (-0.21%)
     
  • CAD/USD

    0.8135
    +0.0009 (+0.11%)
     
  • CRUDE OIL

    72.68
    -0.40 (-0.55%)
     
  • BTC-CAD

    41,662.93
    -500.41 (-1.19%)
     
  • CMC Crypto 200

    816.75
    +6.56 (+0.81%)
     
  • GOLD FUTURES

    1,786.00
    +2.60 (+0.15%)
     
  • RUSSELL 2000

    2,303.47
    +7.52 (+0.33%)
     
  • 10-Yr Bond

    1.4840
    -0.0030 (-0.20%)
     
  • NASDAQ futures

    14,356.75
    +93.75 (+0.66%)
     
  • VOLATILITY

    15.56
    -1.10 (-6.60%)
     
  • FTSE

    7,113.21
    +39.15 (+0.55%)
     
  • NIKKEI 225

    28,875.23
    +0.34 (+0.00%)
     
  • CAD/EUR

    0.6807
    -0.0002 (-0.03%)
     

Prothena: Q1 Earnings Snapshot

·1 min read

DUBLIN (AP) _ Prothena Corp. (PRTA) on Tuesday reported a loss of $36.7 million in its first quarter.

On a per-share basis, the Dublin-based company said it had a loss of 91 cents.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 80 cents per share.

The drug developer posted revenue of $160,000 in the period.

Prothena shares have risen 91% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $22.97, a climb of 90% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTA at https://www.zacks.com/ap/PRTA

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting